This week, we’re discussing the recent U.S. Preventive Services Task Force, or USPSTF, recommendation on colorectal cancer screening beginning at 45. Then, we’ll hear about a doublet regimen that produced durable responses in patients with advanced head and neck cancer. Lastly, we’ll hear about a study being presented during the ASCO Annual Meeting about a novel immunotherapy combination for advanced melanoma.

Coverage of stories discussed this week on ascopost.com:

USPSTF Issues New Recommendation Statement on Colorectal Cancer Screening

Pembrolizumab Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

To listen to more podcasts from ASCO, visit asco.org/podcasts.